Cargando…
Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
BACKGROUND: Timely accrual of a representative sample is a key factor in whether Alzheimer’s disease (AD) clinical trials successfully answer the scientific questions under study. Studies in other fields have observed that, over time, recruitment to trials has become increasingly reliant on larger n...
Autores principales: | Ritchie, Marina, Gillen, Daniel L., Grill, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893207/ https://www.ncbi.nlm.nih.gov/pubmed/36732846 http://dx.doi.org/10.1186/s13195-023-01177-x |
Ejemplares similares
-
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023) -
Recruitment and retention of participant and study partner dyads in two multinational Alzheimer’s disease registration trials
por: Bernstein, Olivia M., et al.
Publicado: (2021) -
A Direction for the Next Decade of NIH-Funded Health Literacy Research
por: Khoong, Elaine C., et al.
Publicado: (2020) -
Attitudes toward clinical trials across the Alzheimer’s disease spectrum
por: Nuño, Michelle M., et al.
Publicado: (2017) -
Recruiting to preclinical Alzheimer's disease clinical trials through registries
por: Grill, Joshua D.
Publicado: (2017)